Tagged with France

Daniel Nizri – President, French League Against Cancer (Ligue Contre le Cancer)
Ipsen’s Aggressive M&A Strategy Pays Off with “New Era of Dynamic Growth”
Clinical Trials: France Strives to Remain Among Europe’s Top Three
Hubert Mechin – President, AFCROs
French Pharma in 2024: 5 Things to Know
France Appoints 6th Health Minister in 6 Years Amid Healthcare System Crisis
France: Industry Demands Easing of Paybacks as Country Bids for Medicine Sovereignty
France Pharma Roundup: MaaT Pharma/Skyepharma Microbiome Facility; Sanofi CNS Drugs Offload; Servier French Site Investment
Three Key Challenges for France’s New Health Minister
French HealthTech More Dynamic and Mature Than Ever Says New Study
France Pharma Roundup: Medicine Shortages; CARMAT’s Artificial Heart Study; Sanofi/Innate Expanded Deal; Cellectis Funding
Understaffed if not Deserted: What’s Ailing French Healthcare?
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here